Brief: Xbrane Biopharma Submits BLA To FDA For Lucentis Biosimilar Candidate

Xbrane Biopharma AB

30/04/2026 07:07

April 30 (Reuters) - Xbrane Biopharma AB XBRANE.ST:

SUBMITS BLA TO FDA FOR LUCENTIS BIOSIMILAR CANDIDATE

Source text: ID:nMFN79W1Rg

Further company coverage: XBRANE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))